High Expression of E2F4 Is an Adverse Prognostic Factor and Related to Immune Infiltration in Oral Squamous Cell Carcinoma.

Yicai Zheng He Fei

Published in: BioMed research international (2022)

E2F4 can be used as a novel biomarker for the diagnosis and prognosis of OSCC.

Keyphrases